TradeFlare's AI research teams analysed ALMS on 5 market nights between June 23, 2026 and September 11, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| September 11, 2026 | HOLD | $9.90 | $12.38 / $8.42 | -15.4% | -22.0% | The technicals are bearish and the risk profile is high, necessitating a cautious approach despite positive fundamental signals. |
| August 13, 2026 | BUY | $25.55 | — / — | -6.3% | -62.4% | Positive clinical development news from ongoing trials. |
| August 4, 2026 | BUY | $26.12 | — / — | -6.5% | -65.1% | The scanner identified a potential mean-reversion opportunity based on RSI pullback. |
| July 30, 2026 | BUY | $26.38 | — / — | -4.0% | -19.8% | Positive analyst ratings and pipeline advancements. |
| June 23, 2026 | BUY | $24.60 | — / — | +14.8% | +17.5% | The market is neutral, and while there's positive sentiment and a post-earnings drift signal, the fundamental bearish outlook and high risk score outweigh the bullish signals. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.